Table 3– Lung function tests in training and test groups
Group A: healthyGroup B: lung cancerGroup C: COPD
VC L4.0±1.04.1±1.03.8±0.8ns3.5±1.12.9±1.13.5±1.1ns2.8±0.8<0.001
VC %107±14111±12103±16<0.0183±2179±2283±2179±20
FEV1 L3.3±0.83.4±0.83.2±0.8ns2.4±0.82.1±1.02.4±0.81.6±0.6
FEV1 %109±15112±13105±17<0.0574±2573±2576±2561±19
FEV1 %VC81.2±5.980.6±5.982.0±5.9ns65±1365±1366±1259±11
TLC L6.0±1.35.9±1.36.0±1.35.8±1.35.9±1.35.8±1.37.1±1.4
TLC %105±18104±13107±2292±2097±2185±16120±20
RV L1.8±1.11.6±0.82.1±1.32.5±1.22.7±1.42.1±0.74.4±1.2
RV %97±5287±30109±69106±49118±5888±25187±56
  • Data are presented as n or mean±sd, unless otherwise stated. COPD: chronic obstructive pulmonary disease; VC: vital capacity; FEV1: forced expiratory volume in 1 s; TLC: total lung capacity; RV: residual lung volume; GOLD: stage of COPD according to the Global Initiative for Chronic Obstructive Lung Disease; ns: nonsignificant. #: training versus test; : for comparison of test groups A, B and C.